Cargando…

Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation

BACKGROUND: Hepatitis B virus (HBV) infection remains a severe public health problem. Investigating its prevalence and trends is essential to prevention. METHODS: To evaluate the effectiveness of HBV vaccination under the 1992 Intervention Program for infants and predicted HBV prevalence trends unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shi-gui, Wang, Bing, Chen, Ping, Yu, Cheng-bo, Deng, Min, Yao, Jun, Zhu, Chun-xia, Ren, Jing-jing, Wu, Wei, Ju, Bin, Shen, Jian-feng, Chen, Yu, Li, Ming D., Ruan, Bing, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477110/ https://www.ncbi.nlm.nih.gov/pubmed/23094094 http://dx.doi.org/10.1371/journal.pone.0047808

Ejemplares similares

Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China
por: Yang, Shigui, et al.
Publicado: (2015)

Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study
por: Chen, Ping, et al.
Publicado: (2017)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
por: Chuai, Xia, et al.
Publicado: (2013)

Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report
por: Das, Manjusha, et al.
Publicado: (2017)

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
por: Coppola, Nicola, et al.
Publicado: (2015)

HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020)

Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan
por: Attaullah, Sobia, et al.
Publicado: (2011)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Impact of targeted vaccination on HBV genotypes in Amsterdam
por: Bruisten, S., et al.
Publicado: (2006)

The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive
por: Guo, Yan, et al.
Publicado: (2022)

Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy
por: Scognamiglio, Paola, et al.
Publicado: (2009)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
por: Cao, Meng Zhuo, et al.
Publicado: (2018)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
por: Torres-Cornejo, Almudena, et al.
Publicado: (2017)

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
por: Ito, Daisuke, et al.
Publicado: (2023)

Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant
por: Zhao, Weidong, et al.
Publicado: (2018)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Optimisation of Prime–Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
por: Chen, Hong, et al.
Publicado: (2012)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
por: Cargill, Tamsin, et al.
Publicado: (2023)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
por: Bayliss, Julianne, et al.
Publicado: (2020)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study
por: Li, Yi, et al.
Publicado: (2020)

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study
por: Ma, Haiyan, et al.
Publicado: (2021)

A type-specific nested PCR assay established and applied for investigation of HBV genotype and subgenotype in Chinese patients with chronic HBV infection
por: Nie, Jing-Jing, et al.
Publicado: (2012)

Elicitation of integrated immunity in mice by a novel pneumococcal polysaccharide vaccine conjugated with HBV surface antigen
por: Qian, Wen, et al.
Publicado: (2020)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
por: Hoogeveen, Ruben C., et al.
Publicado: (2020)

Adherence and Effectiveness of HBV Vaccination among Healthcare Workers in Egypt
por: Elshaer, Mohammed, et al.
Publicado: (2021)

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
por: Qi, Ruoyao, et al.
Publicado: (2023)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine
por: Baroncelli, Silvia, et al.
Publicado: (2021)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon
por: Meriki, Henry Dilonga, et al.
Publicado: (2018)

Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model
por: Zhao, Weidong, et al.
Publicado: (2017)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9geaaodvtluklgike4b3gde02j